NIEPIO-PG2 Tablets

Glimepiride, Metformin Hydrochloride (SR) & Pioglitazone Hydrochloride Tablets

NIEPIO-PG2 Tablets
NIEPIO-PG2 Tablets
NIEPIO-PG2 Tablets
NIEPIO-PG2 Tablets
NIEPIO-PG2 Tablets
DIETARY FOOD SUPPLEMENT

NIEPIO-PG2 Tablets

Glimepiride 2 mg + Metformin Hydrochloride 500 mg (SR) + Pioglitazone 15 mg

  • MAX STRENGTH
  • FILM COATED TABLETS

A tablet formulation containing

PACK SIZE

10 × 15 Tablets

FORM

Uncoated Bilayered Tablets

CATEGORY

Schedule H / Schedule G Prescription Drug

PRODUCT AT A GLANCE

Pack Information

GLIMEPIRIDE

GLIMEPIRIDE

2 mg

METFORMIN HCl. (SR)

METFORMIN HCl. (SR)

500 mg

PIOGLITAZONE

PIOGLITAZONE

15 mg

PACK SIZE

PACK SIZE

10 × 15 Tablets

COMPOSITION

Each Uncoated Bilayered Tablet Contains

Ingredient Amount per Serving
Glimepiride IP 2 mg
Metformin Hydrochloride IP 500 mg
Metformin Hydrochloride In Sustained Release Form
Pioglitazone Hydrochloride IP Equivalent to Pioglitazone 15 mg
Excipients q.s.
Colour Brilliant Blue FCF

Tablet should be swallowed as whole, not to be chewed or crushed.

Each Uncoated Bilayered Tablet Contains
Product Presentation
TABLET & STRIP

Product Presentation

NIEPIO-PG2 is presented as uncoated bilayered tablets in blister strips. The pack is labelled as 10 × 15 tablets, providing 15 tablets per strip and a total pack quantity of 150 tablets.

TABLETS PER STRIP

15 Tablets

PACK PRESENTATION

10 × 15 Tablets

RESPONSIBLE PRODUCT INFORMATION

DOSAGE, STORAGE & IMPORTANT NOTICE

DOSAGE

As directed by the Physician.

STORAGE

Store below 30°C. Protect from light & moisture.

CHILD SAFETY

Keep out of reach of children.

SCHEDULE H PRESCRIPTION DRUG — CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.

Frequently Asked Questions

Product FAQ'S

NIEPIO-PG2 is a prescription medicine presented as uncoated bilayered tablets containing Glimepiride, Metformin Hydrochloride in sustained release form, and Pioglitazone Hydrochloride.

Each uncoated bilayered tablet contains Glimepiride IP 2 mg, Metformin Hydrochloride IP 500 mg in sustained release form, and Pioglitazone Hydrochloride IP equivalent to Pioglitazone 15 mg. It also contains excipients q.s. and Brilliant Blue FCF as colour.

NIEPIO-PG2 is supplied in a 10 × 15 Tablets pack, containing 15 tablets per blister strip and 150 tablets in the complete pack.

The dosage should be followed as directed by the physician. The tablet should be swallowed whole and should not be chewed or crushed.

Store below 30°C and protect from light and moisture. Keep out of reach of children.

Yes. The product packaging carries Schedule H and Schedule G prescription-drug cautions and states that it should be taken under medical supervision.

NIEPIO-PG2 is manufactured by Lifevision Healthcare, a WHO-GMP Certified Company.

NIEPIO-PG2 is marketed by BIO SAHANI HEALTHCARE, Ashok Nagar, Kolkata, West Bengal.

The packaging includes specific safety information relating to Pioglitazone, including precautions concerning bladder cancer, uninvestigated haematuria, treatment review, elderly patients, and the risk of heart failure associated with Pioglitazone.